EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction

Lucas Rempel iD, Raza N Malik, Claire Shackleton, Martín Calderón-Juárez, Rahul Sachdeva iD, Andrei V Krassioukov iD

Toxins · 2024

DOI: 10.3390/toxins16020096 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, 2024. Verfasst von Lucas Rempel und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Collaboration on Repair Discoveries, Faculty of Medicine, The University of British Columbia, Vancouver, BC V5Z 1M9, Canada. Hauptthemen laut MEDLINE: Botulinum Toxins, Botulism, Clostridium botulinum, Autonomic Nervous System Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since its regulatory approval over a half-century ago, botulinum toxin has evolved from one of the most potent neurotoxins known to becoming routinely adopted in clinical practice. Botulinum toxin, a highly potent neurotoxin produced by Clostridium botulinum, can cause botulism illness, characterized by widespread muscle weakness due to inhibition of acetylcholine transmission at neuromuscular junctions. The observation of botulinum toxin’s anticholinergic properties led to the investigation of its potential benefits for conditions with an underlying etiology of cholinergic transmission, including autonomic nervous system dysfunction. These conditions range from disorders of the integument to gastrointestinal and urinary systems. Several formulations of botulinum toxin have been developed and tested over time, significantly increasing the availability of this treatment for appropriate clinical use. Despite the accelerated and expanded use of botulinum toxin, there lacks an updated comprehensive review on its therapeutic use, particularly to treat autonomic dysfunction. This narrative review provides an overview of the effect of botulinum toxin in the treatment of autonomic dysfunction and summarizes the different formulations and dosages most widely studied, while highlighting reported outcomes and the occurrence of any adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum ToxinsBotulismClostridium botulinumAutonomic Nervous System DiseasesHumansNeurotoxins

Stichwörter der Autor:innen

autonomic dysfunctionbacterial toxinbotulinum toxin

Substanzen

Botulinum ToxinsNeurotoxins

Autor:innen und Institutionen

  • International Collaboration on Repair Discoveries, Faculty of Medicine, The University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
  • Division of Physical Medicine and Rehabilitation, Department of Medicine, The University of British Columbia, Vancouver, BC V5Z 2G9, Canada.
  • GF Strong Rehabilitation Centre, Vancouver Coastal Health, Vancouver, BC V5Z 2G9, Canada.

ORCID-Profile: Lucas Rempel, Rahul Sachdeva, Andrei V Krassioukov

Zitieren

APA

Rempel, L., Malik, R. N., Shackleton, C., Calderón-Juárez, M., Sachdeva, R., & Krassioukov, A. V. (2024). From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction. Toxins. https://doi.org/10.3390/toxins16020096

Vancouver

Rempel L, Malik RN, Shackleton C, Calderón-Juárez M, Sachdeva R, Krassioukov AV. From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction. Toxins. 2024. doi:10.3390/toxins16020096

BibTeX
@article{Rempel2024,
  author = {Rempel, Lucas and Malik, Raza N and Shackleton, Claire and Calderón-Juárez, Martín and Sachdeva, Rahul and Krassioukov, Andrei V},
  title = {From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16020096}
}
Kostenlos starten →